Physician profile
Wayne M Grabowski
NPI 1588774046
$4,926.75
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $98.78 · 2021: $4,371.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $4,370.77 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $113.64 | 2019 | |
| Alcon Vision LLC | $88.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $61.36 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $56.39 | 2019-2020 | |
| Eyepoint US, INC. | $47.00 | 2019-2020 | |
| Allergan, INC. | $44.79 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $30.11 | 2019 | |
| Genentech USA, INC. | $29.21 | 2019 | |
| Sun Pharmaceutical Industries INC. | $28.65 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $22.44 | 2020 | |
| Abb Con-Cise Optical Group LLC | $21.27 | 2019 | |
| Ocular Therapeutix, INC. | $12.95 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Grabowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.